• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Parkinson’s Disease Global Clinical Trials Review, H2, 2011
 

Parkinson’s Disease Global Clinical Trials Review, H2, 2011

on

  • 510 views

GlobalData’s “Parkinson’s Disease Global Clinical Trials Review, H2, 2011” is now available at Marketreportsonline.com.

GlobalData’s “Parkinson’s Disease Global Clinical Trials Review, H2, 2011” is now available at Marketreportsonline.com.

Statistics

Views

Total Views
510
Views on SlideShare
510
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Parkinson’s Disease Global Clinical Trials Review, H2, 2011 Parkinson’s Disease Global Clinical Trials Review, H2, 2011 Document Transcript

    • Parkinson’s Disease Global Clinical Trials Review, H2,2011Published:October 2011No. of Pages:119Price:$1000Parkinson’s Disease Global Clinical Trials Review, H2, 2011SummaryGlobalDatas clinical trial report, “Parkinson’s Disease Global Clinical Trials Review, H2,2011" provides data on the Parkinson’s Disease clinical trial scenario. This reportprovides elemental information and data relating to the clinical trials onParkinson’s Disease. It includes an overview of the trial numbers and theirrecruitment status as per the site of trial conduction across the globe. The databookoffers a preliminary coverage of disease clinical trials by their phase, trial status,prominence of the sponsors and also provides briefing pertaining to the number of trialsfor the key drugs for treating Parkinson’s Disease. This report is built using data andinformation sourced from proprietary databases, primary and secondary research andin-house analysis by GlobalDatas team of industry experts.Note: Certain sections in the report may be removed or altered based on the availabilityand relevance of data for the indicated disease.Scope- Data on the number of clinical trials conducted in North America, South and CentralAmerica, Europe, Middle-East and Africa and Asia-pacific and top five nationalcontributions in each, along with the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruitedand sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment,location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe
    • - Espy the commercial landscape of the major Universities / Institutes / Hospitals orCompaniesTable of ContentsTable of Contents 2List of Tables 5List of Figures 7Introduction 8Parkinson’s Disease 8Report Guidance 8Clinical Trials by Region 9Clinical Trials by Country 10Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12Top Five Countries Contributing to Clinical Trials in Europe 13Top Countries Contributing to Clinical Trials in North America 14Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15Top Five Countries Contributing to Clinical Trials in Central and South America 16Clinical Trials by BRIC Nations 17Clinical Trials by G7 Nations 18Clinical Trials in G7 Nations by Trial Status 19Clinical Trials by E7 Nations 20Clinical Trials in E7 Nations by Trial Status 21Clinical Trials by Phase 22In Progress Trials by Phase 23Clinical Trials by Trial Status 24Unaccomplished Trials of Parkinson’s Disease 25Subjects Recruited Over a Period of Time 31Prominent Sponsors 32Top Companies Participating in Parkinson’s Disease Therapeutics Clinical Trials 34Prominent Drug Comparison 36Clinical Trial Profiles 37Clinical Trial Overview of Top Companies 37Boehringer Ingelheim GmbH 37Clinical Trial Overview of Boehringer Ingelheim GmbH 37Novartis AG 40Clinical Trial Overview of Novartis AG 40UCB S.A. 43Clinical Trial Overview of UCB S.A. 43Kyowa Hakko Kirin Co., Ltd. 45Clinical Trial Overview of Kyowa Hakko Kirin Co., Ltd. 45Teva Pharmaceutical Industries Limited 47Clinical Trial Overview of Teva Pharmaceutical Industries Limited 47Merck & Co., Inc. 49Clinical Trial Overview of Merck & Co., Inc. 49Abbott Laboratories 51
    • Clinical Trial Overview of Abbott Laboratories 51GlaxoSmithKline plc 52Clinical Trial Overview of GlaxoSmithKline plc 52Eisai Inc. 54Clinical Trial Overview of Eisai Inc. 54IMPAX Laboratories, Inc. 55Clinical Trial Overview of IMPAX Laboratories, Inc. 55Pfizer Inc. 56Clinical Trial Overview of Pfizer Inc. 56Eli Lilly and Company 57Clinical Trial Overview of Eli Lilly and Company 57Orion Corporation 58Clinical Trial Overview of Orion Corporation 58EMD Serono, Inc. 59Clinical Trial Overview of EMD Serono, Inc. 59ACADIA Pharmaceuticals Inc. 60Clinical Trial Overview of ACADIA Pharmaceuticals Inc. 60Biogen Idec Inc. 61Clinical Trial Overview of Biogen Idec Inc. 61Newron Pharmaceuticals S.p.A. 62Clinical Trial Overview of Newron Pharmaceuticals S.p.A. 62Otsuka Pharmaceutical Co., Ltd. 63Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 63Dainippon Sumitomo Pharma Co., Ltd. 64Clinical Trial Overview of Dainippon Sumitomo Pharma Co., Ltd. 64Sanofi 65Clinical Trial Overview of Sanofi 65Clinical Trial Overview of Top Universities / Institutes / Hospitals 66National Institute of Neurological Disorders and Stroke 66Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 66Institute for Neurodegenerative Disorders 68Clinical Trial Overview of Institute for Neurodegenerative Disorders 68Oregon Health and Science University 70Clinical Trial Overview of Oregon Health and Science University 70Radboud University 71Clinical Trial Overview of Radboud University 71Washington University School of Medicine 72Clinical Trial Overview of Washington University School of Medicine 72University of Rochester 73Clinical Trial Overview of University of Rochester 73Vanderbilt University 74Clinical Trial Overview of Vanderbilt University 74Dresden University of Technology 75Clinical Trial Overview of Dresden University of Technology 75Baylor College of Medicine 76
    • Clinical Trial Overview of Baylor College of Medicine 76The University of South Florida 77Clinical Trial Overview of The University of South Florida 77Institut National de la Sante et de la Recherche Medicale 78Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 78UNIVERSITY HOSPITAL, CLERMONT-FERRAND 79Clinical Trial Overview of UNIVERSITY HOSPITAL, CLERMONT-FERRAND 79University of Florida 80Clinical Trial Overview of University of Florida 80Tel-Aviv Sourasky Medical Center 81Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 81University of Minnesota 82Clinical Trial Overview of University of Minnesota 82University of Medicine and Dentistry New Jersey 83Clinical Trial Overview of University of Medicine and Dentistry New Jersey 83Rush University Medical Center 84Clinical Trial Overview of Rush University Medical Center 84University of Colorado 85Clinical Trial Overview of University of Colorado 85University Hospital, Toulouse 86Clinical Trial Overview of University Hospital, Toulouse 86Seoul National University Hospital 87Clinical Trial Overview of Seoul National University Hospital 87Five Key Clinical Profiles 88Appendix 115Abbreviations 115Definitions 115Research Methodology 117Secondary Research 117About GlobalData 118Contact Us 118Disclaimer 118Source 119Latest Research Reports:  The Indian Mining Industry – Market Opportunities and Entry Strategies, Analyses and Forecasts to 2015  Abbott Medical Device Company Intelligence Report  Nihon Kohden Medical Device Company Intelligence Report  Global OCTG (Oil Country Tubular Goods) Market Report: 2011 Edition  Global Luxury Goods Market Report: 2011 Edition
    •  US Pharmacy Benefit Management (PBM) Industry Report: 2011 Edition  Global OCTG (Oil Country Tubular Goods) Market Report: 2011 EditionAbout Us:MarketReportsOnline is comprising of an online library of 50,000 reports, in-depthmarket research studies of over 5000 micro markets, and 25 industry specific websites.We provide 24/7 online and offline support to our customers. Get in touch with us foryour needs of market research reports.Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: + 1 888 391 5441E-mail: sales@marketreportsonline.comhttp://marketreportsonline.com/